Abstract
Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) has posed significant threats to the public health and life in China. Unlike the other 6 identified coronaviruses, the SARS-Cov-2 has a high infectious rate, a long incubation period and a variety of manifestations. In the absence of effective treatments for the virus, it becomes extremely urgent to develop scientific and standardized proposals for prevention and control of virus transmission. Hereby we focused on the surgical practice in Neurosurgery Department, Tongji Hospital, Wuhan, and drafted several recommendations based on the latest relevant guidelines and our experience. These recommendations have helped us until now to achieve ‘zero infection’ of doctors and nurses in our department, we would like to share them with other medical staff of neurosurgery to fight 2019-nCoV infection.
Key words: SARS-CoV-2, Neurosurgery, Diagnosis, Treatment, Prevention
Conflict of Interest Statement
None.
Contributor Information
Yu-tang Tan, Email: 5364478@qq.com.
Kai Shu, Email: Kshu@tjh.tjmu.
Ting Lei, Email: tlei@tjh.tjmu.edu.cn.
References
- 1.Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wu F, Zhao S Y %, et al. Nature. 2020. A new coronavirus associated with human respiratory disease in China. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Pan X, Ojcius DM, Gao T, et al. Microbes Infect. 2020. Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sun P, Lu X, Xu C, et al. J Med Virol. 2020. Understanding of COVID-19 based on current evidence. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Zhao WM, Song SH, Chen ML, et al. The 2019 novel coronavirus resource. Yi Chuan. 2020;42(2):212–221. doi: 10.16288/j.yczz.20-030. [DOI] [PubMed] [Google Scholar]
- 6.Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi: 10.1016/S0140-6736(20)30251-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ralph R, Lew J, Zeng T, et al. 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. J Infect Dev Ctries. 2020;14(1):3–17. doi: 10.3855/jidc.12425. [DOI] [PubMed] [Google Scholar]
- 8.Wang D, Hu B, Hu C, et al. JAMA. 2020. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lai CC, Shih TP, Ko WC, et al. Int J Antimicrob Agents. 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges; p. 105924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ai T, Yang Z, Hou H, et al. Radiology. 2020. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases; p. 200642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Shanmugaraj B, Malla A, Phoolcharoen W. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development. Pathogens. 2020;9(2):148–150. doi: 10.3390/pathogens9020148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kwok KO, Wong V, Wei VWI, et al. J Infect. 2020. Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread. [DOI] [PMC free article] [PubMed] [Google Scholar]